EndoTODAY | EndoATLAS | ¿Ü·¡¼³¸íÀÚ·á

±â»ýÃæ | ½Äµµ | À§ | À§¾Ï | ESD | õ±â´©¼³

Home | Guide | ÁÖÀÎÀå | ±¸µ¶ | °Ë»ö | ¸µÅ©


[ÀÏ¿ø³»½Ã°æ±³½Ç ¸ñ¿äÁ¡½ÉÁý´ãȸ 2016-6-2]

Previous | Next

1. Gastric neuroendocrine tumor

À§ granular cell tumor¶ó°í ÀǷڵǾú½À´Ï´Ù. ±×·¯³ª ¿ÜºÎº´¸®½½¶óÀ̵å ÀçÆǵ¶¿¡¼­´Â neuroendocrine tumor, granular cell tumorÀÇ °¡´É¼ºÀÌ ¸ðµÎ ÀÖ´Ù°í º¸°íµÇ¾ú½À´Ï´Ù. ESD¸¦ ½ÃÇàÇÏ¿´°í ÃÖÁ¾ °á°ú´Â ¾Æ·¡¿Í °°¾Ò½À´Ï´Ù. Ç÷û gastrinÀº 778 pg/mLÀ̾ú½À´Ï´Ù. °ú°Å Á¦1Çü À¯¾ÏÁ¾À̶ó°í ºÎ¸£´ø º´ÀÔ´Ï´Ù.

Stomach, endoscopic submucosal dissection:
Well-differentiated neuroendocrine tumor (G1)
1. Name of Procedure: ESD
2. Site of Tumor: Stomach (low body, greater curvature)
3. Diagnosis: Neuroendocrine tumor
4. WHO classification(2010): Neuroendocrine tumor(G1)
5. Multiplicity: Single
6. Size: 0.4x0.4 cm
7. Extent: Mucosa and submucosa
8. Grading: Mitotic Count: 1/5 HPFs, Ki-67 labeling index: 2 %
9. Immunohistochemical Stains: (1) Synaptophysin : Positive, (2) Chromogranin A: Positive
10. Lymphovascular invasion: Not identified
11. Perineural invasion: Not identified
12. Lymph node metastasis: Not evaluated
13. Resection Margins: Negative

* Âü°í: EndoTODAY À§À¯¾ÏÁ¾


2. Diffuse large B cell lymphoma

Å« massÀÌ°í Áß¾Ó¿¡ ³ÐÀº ±Ë¾çÀÌ ÀÖ½À´Ï´Ù. ±Ë¾ç ¿·ÀÇ À¶±âºÎ´Â BGU¿¡¼­ º¸ÀÌ´Â edematous marginÀÌ ¾Æ´Ï¶ó ±Ë¾çÀ» µÑ·¯½Î°í ÀÖ´Â °ß°íÇÑ heaped up marginÀÔ´Ï´Ù. AGC B-II Ä¡°í´Â ³Ê¹« Å©°í, AGC-B-III Ä¡°í´Â ³Ê¹« ±ú²ýÇÕ´Ï´Ù. AGC°¡ À̸¸Å­ Å« °æ¿ì´Â º¸Åë Á» ´õ infiltrativeÇÑ ¾ç»óÀ» º¸ÀÌ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ±×·¡¼­ lymphoma¸¦ ÀǽÉÇØ¾ß ÇÕ´Ï´Ù.

Áý´ãȸ µµÁß ÀÌ È¯ÀÚÀÇ Áø´Ü¿¡ ´ëÇÏ¿© PingpongÀ̶ó´Â appÀ» ÀÌ¿ëÇÏ¿© votingÀ» ÇØ º¸¾Ò½À´Ï´Ù. (1) BGU, (2) AGC, (3) Others Áß ¼±ÅÃÅä·Ï ¹®Á¦¸¦ ³Â½À´Ï´Ù. 12ºÐ Áß 6ºÐÀÌ Á¤È®ÇÏ°Ô (3) others¸¦ ¼±ÅÃÇØ Áּ̽À´Ï´Ù. Áý´ãȸ¸¦ ¹Ýº¹Çϸ鼭 Á¡Á¡ ½Ç·ÂÀÌ Çâ»óµÊÀ» ´À³§´Ï´Ù. ¿©·¯ºÐ. °Ë»çÇÏ°í °øºÎÇÏ´À¶ó ¼ö°í°¡ ¸¹À¸¼Ì½À´Ï´Ù.

Diffuse large B cell lymphomaÀÇ ´Ù¾çÇÑ ³»½Ã°æ ¼Ò°ßÀº ¿©±â¸¦ ÂüÁ¶ÇÏ¸é µË´Ï´Ù. ±× Áß ¿À´ÃÀÇ Áõ·Êó·³ ulcerative mass¿´´ø °æ¿ì¸¦ ¼Ò°³ÇÕ´Ï´Ù.

* Âü°í: EndoTODAY DLBCL


3. Rectal endometriosis

»ý¸®Áֱ⿡ ¹èº¯ ½Ã ÅëÁõÀÌ ÀÖ°í ÁúÃâÇ÷µµ ´Ã¾î¼­ »êºÎÀΰú¿¡¼­ Pelvix MRI¸¦ ÇÏ¿´°í ÀÌ»ó¼Ò°ßÀÌ À־ ´ëÀå³»½Ã°æ °Ë»ç¸¦ ¹ÞÀ¸¼Ì½À´Ï´Ù.

MRI Æǵ¶ °á°ú: PelvisÀÇ posterior cul-de-sac¿¡ infiltrative ill-defined soft-tissue mass lesionÀÌ ÀÖÀ¸¸ç ÀÌ mass´Â upper vaginaÀÇ posterior fornix, rectosigmoid colonÀ» ħ¹üÇÏ°í ÀÖÀ½. Å©±â´Â ´ë·« 3.7 cm Á¤µµµÊ. ³»ºÎ¿¡ hemorrhage¸¦ µ¿¹ÝÇÑ spotsµîÀÌ Æ÷ÇԵǾî ÀÖ¾î endometriosis·Î ÆǴܵÊ. Left ovary³»¿¡µµ 2 cm ÀÌÇÏÀÇ ´ë·« 3-4°³ Á¤µµÀÇ endometriomas°¡ µ¿¹ÝµÇ¾î ÀÖÀ½.

´ëÀå³»½Ã°æ¿¡¼­´Â ¾Æ·¡¿Í °°Àº ¼Ò°ßÀ̾ú½À´Ï´Ù (From AV 15cm to AV 11cm, about 4cm sized ill-defined flat elevated lesion with hard consistent, non-movable, surface hyperemic change was seen.)

Rev Esp Enferm Dig. 2016¿¡¼­ ¿Å±é´Ï´Ù. Intestinal endometriosis is defined as a bowel infiltration by ectopic endometrial tissue. The prevalence is 3-37% of all women affected by endometriosis. Rectosigmoid colon is the most frequent location (70-93%), followed to ileocecal region, appendix and other colon and small bowel segments. Intestinal endometriosis usually is asymptomatic. Often it is only diagnosed during surgery for other reasons. The symptoms frequently are nonspecific, although it may appear as an acute abdominal pain. Clinical history, physical examination and image techniques are necessary for the diagnosis. The choice of the operative technique depends on the clinical presentation and on the fertility wishes of the patient. Laparotomy and laparoscopy are equally effective, but laparoscopic approach is preferred.

Á¦°¡ °æÇèÇÏ¿´´ø Áõ·Ê ¸î °³¸¦ ¼Ò°³ÇÕ´Ï´Ù.

¹«Áõ»ó °ËÁø³»½Ã°æ

¹«Áõ»ó °ËÁø³»½Ã°æ

Rectal bleeding during mestruation period

°Ç°­°ËÁø¿¡¼­ ¹ß°ßµÈ cecal massÀÔ´Ï´Ù. CT¿¡¼­ ¾à 2 cm Å©±âÀÇ oval enhancing mass°¡ cecal base¿¡¼­ ¹ß°ßµÇ¾ú°í GISTÀÇ °¡´É¼ºÀÌ ÀÖ´Â °ÍÀ¸·Î Æò°¡µÇ¾ú½À´Ï´Ù. ±×¸®°í ¿ì¿¬È÷ ovary¿Í salpinx¿¡¼­ cyst mass°¡ ¹ß°ßµÇ¾î joint operationÀ¸·Î salpingo-oophorectomy¿Í cecectomy¸¦ ½ÃÇàÇÏ¿´½À´Ï´Ù. °á°ú´Â ¸ðµÎ endometriosis¿´½À´Ï´Ù.

* Âü°í: EndoTODAY Àڱ󻸷Áõ


4. Esophageal neuroendocrine carcinoma mixed with adenocarcinoma

Esophagus and upper stomach, Ivor Lewis operation :
Mixed poorly differentiated neuroendocrine carcinoma and adenocarcinoma,
1) tumor size: 2x1.5 (neuroendocrine carcinoma 99%, adenocarcinoma 1%)
2) extension to submucosa
3) mitosis: 52/10 HPFs
4) necrosis: present
5) lymphovascular invasion: present
6) perineural invasion: not identified
7) resection margins: free from carcinoma, circumferential (adventitial) margin(deep), 0.4cm
8) metastasis to 7 out of 44 regional lymph nodes (7/44: "RRLN", 0/6; "LRLN", 0/6; "RD", 1/1; "G1", 2/6; "G2", 0/2; "G3", 0/8; "2R", 2/3; "7", 1/3; "8u", 1/3; "9R", 0/2; "10L", 0/4)
AJCC pathologic stage: pT1b N2


[References]

1) SMC Endoscopy Unit »ï¼º¼­¿ïº´¿ø ³»½Ã°æ½Ç

2) SMC Monday GI conference »ï¼º¼­¿ïº´¿ø ÀÏ¿ø³»½Ã°æ±³½Ç ¿ù¿äÁ¡½É¼ÒÈ­±âÁý´ãȸ

3) SMC Thursday endoscopy conference »ï¼º¼­¿ïº´¿ø ÀÏ¿ø³»½Ã°æ±³½Ç ¸ñ¿äÁ¡½É³»½Ã°æÁý´ãȸ

© EndoTODAY Endoscopy Learning Center. Jun Haeng Lee.